The contribution of observational studies in supporting the WHO ‘treat all’ recommendation for HIV/AIDS

In 2015, the World Health Organization (WHO) recommended that all people living with HIV (PLWH) should start antiretroviral therapy (ART) irrespective of clinical or immune status. This recommendation followed almost 20 years of research into the clinical and population-level benefits and risks of s...

Full description

Bibliographic Details
Main Authors: Nathan Ford, Martina Penazzato, Marco Vitoria, Meg Doherty, Mary-Ann Davies, Elizabeth Zaniewski, Olga Tymejczyk, Matthias Egger, Denis Nash
Format: Article
Language:English
Published: Elsevier 2018-11-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020303460
Description
Summary:In 2015, the World Health Organization (WHO) recommended that all people living with HIV (PLWH) should start antiretroviral therapy (ART) irrespective of clinical or immune status. This recommendation followed almost 20 years of research into the clinical and population-level benefits and risks of starting ART early compared with deferring treatment. This article summarises the ways in which observational data support the work of WHO, including the support provided by the International epidemiology Databases to Evaluate AIDS (IeDEA), taking the example of ‘treat all’.
ISSN:2055-6640